However, dystroglycanopathy mouse models lack DG-ECM linkage while retaining dystrophin (40) and, therefore, are capable of anchoring microtubules to dystrophin. The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.